Laquinimod T6561
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Laquinimod is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy.
CAS nr:
248281-84-7
Purity:
98%
Molecular Weight:
356,8
SMILES:
CCN(C(=O)c1c(O)c2c(cccc2Cl)n(C)c1=O)c1ccccc1
Formula:
C19H17ClN2O3
Pathway:
Others,NF-_b,Apoptosis
Target:
Others,NF-_B,Apoptosis
